Zynx Health's competitors

Zynx Health's competitors include Advanced Oncotherapy, Affymetrix, Orthofix and Fusion Antibodies
Add company...
Zynx Health
Zynx Health, a subsidiary of Hearst Corporation, is the market leader in providing evidence-based and experience-based clinical decision.
Advanced Oncotherapy
Advanced Oncotherapy is a medical technology company providing advanced radiotherapy systems for the treatment of common and rare cancers.
Affymetrix
Affymetrix now develops and provides innovative technologies that enable multiplex and parallel analysis of biological systems at the cell,
Orthofix
Orthofix International is a diversified, global medical device company focused on improving patients' lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide.
Fusion Antibodies
Fusion Antibodies is a CRO that offers a range of world class services in antibody production, development, characterization and optimization.
Founding Date
Founding Date
1996
Founding Date
1994
Founding Date
1994
Founding Date
1980
Founding Date
2001
Type
Type
Private
Type
Public
Type
Subsidiary
Type
Public
Type
Private
Tags
Locations
Locations
Los Angeles, US HQ
Locations
London, GB HQ
Rolle, CH
Syracuse, US
Locations
Santa Clara, US HQ
Vienna, AT
Shanghai, CN
Singapore, SG
High Wycombe, GB
San Diego, US
see more
Locations
Z.a.i., IT HQ
São Paulo, BR
Willemstad, CW
Arcueil, FR
Ottobrunn, DE
Sona, IT
San Juan, PR
see more
Locations
Dunmurry, GB HQ
Employees
Employees
1071% increase
Employees
51
Employees
1,150
Employees
938
Employees
23
Valuation ($)
Valuation ($)
N/A
Valuation ($)
28.9 m
Valuation ($)
N/A
Valuation ($)
1 b
Valuation ($)
N/A
Facebook likes
Facebook likes
N/A
Facebook likes
928
Facebook likes
65 k
Facebook likes
14
Facebook likes
225
Twitter followers
Twitter followers
823
Twitter followers
804
Twitter followers
9.8 k
Twitter followers
N/A
Twitter followers
780

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$359.8m (FY, 2015)
Revenue (est.)
$433.8m (FY, 2017)
Revenue (est.)
£1.9m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$110.8m (FY, 2015)
Cost of goods
$93m (FY, 2017)
Cost of goods
£952.5k (FY, 2017)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$249m (FY, 2015)
Gross profit
$340.8m (FY, 2017)
Gross profit
£961.5k (FY, 2017)
Net income
Net income
N/A
Net income
(£10.4m) (FY, 2016)
Net income
$10.1m (FY, 2015)
Net income
$6.2m (FY, 2017)
Net income
£120k (FY, 2017)
For sources of this data, please see the company profileDownload Excel

View company profiles

Advanced Oncotherapy
HQ
London, GB
Employees
51

Advanced Oncotherapy is a medical technology company providing advanced radiotherapy systems for the treatment of common and rare cancers.

View company
Affymetrix
HQ
Santa Clara, US

Affymetrix now develops and provides innovative technologies that enable multiplex and parallel analysis of biological systems at the cell,

View company
Orthofix
HQ
Z.a.i., IT
Employees
938

Orthofix International is a diversified, global medical device company focused on improving patients' lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide.

View company
Fusion Antibodies
HQ
Dunmurry, GB
Employees
23

Fusion Antibodies is a CRO that offers a range of world class services in antibody production, development, characterization and optimization.

View company